← Back to Search

Zavegepant for Asthma

Phase 1
Waitlist Available
Research Sponsored by Biohaven Pharmaceuticals, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-7 hours
Awards & highlights

Study Summary

This trial is testing whether an active drug is better than a placebo at treating asthma. The trial is double-blind, meaning that neither the participants nor the researchers will know who is receiving the active drug or the placebo. The trial is also randomized, meaning that participants will be assigned to either the active drug or the placebo group by chance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-7 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-7 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Allergen induced late asthmatic response (LAR)

Side effects data

From 2021 Phase 3 trial • 1978 Patients • NCT04571060
21%
Dysgeusia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Zavegepant 10 mg
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BHV3500Experimental Treatment1 Intervention
Zavegepant 150 mg BID
Group II: PlaceboPlacebo Group1 Intervention
Matching placebo 150 mg BID
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Zavegepant
2019
Completed Phase 3
~4150

Find a Location

Who is running the clinical trial?

Biohaven Pharmaceuticals, Inc.Lead Sponsor
47 Previous Clinical Trials
37,120 Total Patients Enrolled
PfizerLead Sponsor
4,568 Previous Clinical Trials
10,911,871 Total Patients Enrolled
39 Trials studying Asthma
62,120 Patients Enrolled for Asthma
Pfizer CT.gov Call CenterStudy DirectorPfizer
3,475 Previous Clinical Trials
8,093,039 Total Patients Enrolled
16 Trials studying Asthma
1,019 Patients Enrolled for Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research open to individuals aged twenty and above?

"This trial is enrolling adults aged 18 to 65."

Answered by AI

How many individuals are participating in this research project?

"To conduct the trial, 24 participants that meet specific criteria must be enrolled. Biohaven Pharmaceuticals, Inc., is responsible for recruiting from various sites including Edmonton in British Columbia and Quebec in Ontario."

Answered by AI

Are there any available spots for people to join this experiment?

"Clinicaltrials.gov indicates that this medical trial, initially posted on October 18th 2021 and most recently updated November 14th 2022, is still recruiting patients."

Answered by AI

What are the requirements for entering this medical study?

"This clinical trial is looking for 24 patients above the age of consent and below 65 that are suffering from asthma. To be eligible, individuals must meet a baseline set of criteria pertaining to their condition."

Answered by AI

How many medical facilities are hosting this clinical trial?

"This trial is running in 6 locations across the country, including Edmonton, Quebec and Vancouver. To minimize travel time for participants, pick a site nearest to you."

Answered by AI

Does this trial involve any original or novel approaches?

"Since its initial 2021 clinical trial, conducted by Biohaven Pharmaceutical Holding Company Ltd. and involving 2900 patients, Zavegepant has seen a total of 18328 studies to date across 97 urban centres in two nations."

Answered by AI

Could you please provide a synopsis of prior experiments involving Zavegepant?

"At present, there exists 2 separate trials exploring Zavegepant with the most advanced one being in Phase 3. Although studies are primarily based out of Kansas City, MO, 106 other sites have been approved for conducting investigations on this drug."

Answered by AI

Is Zavegepant a risk-free medication for people to take?

"Limited evidence exists supporting the safety and efficacy of Zavegepant, so it has been assigned a score of 1."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma
2021. "Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04987944.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top